Early Access — free while we kick the tires
EdgarHawk

ERAS Erasca, Inc. Insider Trading

Latest: CLO Sold $1.3M of Shares · Apr 2026
2 filings analyzed · Latest 2026-04-03
Insider buys
0
Insider sells
2
Unique insiders
1
Direction
Net selling
April 2026
2026-04-03
high
Garner Ebun Sell
Chief Legal Officer
80,000 shares
$1,312,000
@ $16.40
Significance 6/10

CLO Garner Ebun sold 80,000 shares of ERAS at $16.40 on 2026-04-01, reducing stake by 76.1% to 25,076 shares post-transaction.

Garner Ebun, Chief Legal Officer, executed a material open-market sale of 80,000 shares at $16.40 on 2026-04-01, divesting 76.1% of his pre-transaction holdings. The stock has since appreciated to $17.81 (the 52-week high), trading at +26.3% over the past 30 days and +396.1% over the past 90 days—a strong recovery environment. At ERAS specifically, his prior sell on 2026-01-07 delivered a +119.8% 30-day return, indicating recent trades at this ticker have underperformed on a timing basis given the subsequent price momentum. The company remains unprofitable with net income of $-30,612,000 over the most recent full fiscal year, providing context for executive liquidity decisions even as the equity has recovered sharply.

January 2026
2026-01-08
high
Garner Ebun Sell
General Counsel & Corp. Sec.
120,000 shares
$670,812
@ $5.59
Significance 7/10

General Counsel Garner Ebun sells 120,000 shares (82.7% of holdings) at $5.59 as ERAS peaks at 52-week high

Garner Ebun, serving as General Counsel & Corporate Secretary, executed a substantial sale of 120,000 shares at $5.59 on 2026-01-07, reducing his post-transaction holdings to 25,076 shares—a net reduction of 82.7% of his pre-transaction position. The sale occurred as the stock reached its 52-week high of $5.81, with the stock having appreciated 76.1% over the prior 30 days and 141.1% over 90 days. This timing—disposing of the majority of his equity position at a cyclical peak after sustained appreciation—stands in contrast to the company's fundamentals: Erasca remains unprofitable with a net loss of $30,612,000.00 in its most recent full fiscal year. The combination of a major equity stake reduction by a senior executive at near-peak valuation, coupled with persistent losses and limited remaining holdings, warrants investor attention to the company's near-term trajectory and management's confidence in sustainability.

Get alerts for ERAS

Add ERAS to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access